Cell growth kinetics of APC-stimulated breast cancer cell lines. A. MTS proliferation assay of cells stimulated with increasing doses of APC. Data were normalized with absorbance values from day 0. Each dot represents mean ± SD of six replicates. B. Percentage of cells in each phase of the cell cycle in control and 50 nM APC-stimulated cells for 24 and 48 h, in serum-free and 4% serum medium. C. Percentage of apoptotic cells in basal and staurosporine-induced conditions, measured by annexin-V binding flow cytometry assay. Cell lines are MDA-MB-231,1833, BT-549, and ANV5, from the left to the right, in all figure sections. (PPTX 325 kb
Figure S8. The growth kinetics of MDA-468/shCtrl cells or MDA-468/shIRIS cell lines grown alone or i...
Figure S2. Anti-proliferative effect of RAD001 in combination with endocrine agents (a) 4-OHT and (b...
Figure S1: (A) Dysregulation score was calculated according to Pathifier [32] for MAPK and JAK/STAT ...
Cell growth kinetics in 2D cultures of human breast cancer cell lines after SPOCK1 silencing. A. Ana...
KaplanâMeier analysis in different molecular subtypes of breast cancer patients based on EPCR expr...
Clinical relevance of SPOCK1 in different breast cancer subtypes. A. Relapse-free survival analysis ...
Figure S2. ED and EAD induce cell growth arrest. (A) qRT-PCR of cyclin D1 (CCND1) and cyclin-depende...
Role of MAPK and PI3K pathways in APOBEC3 activation. a BT474 cells were treated with 10 nM afatinib...
PRKCQ downregulation in MDA-231-LucD3H2LN cells results in G2-M arrest. Triple-negative MDA-231-LucD...
Figure S7. Assessment of dynamic changes in expression of cell cycle regulatory genes. (a) Log2 diff...
Figure S7. Test of cell line-specific variance in colony-forming assay between 4T1.2-shLacZ and 4T1....
Role of MAPK and PI3K pathways in hydroxyurea-induced APOBEC3 activation. a MCF10A cells were treate...
APOBEC3B expression and activity in breast cancer cell lines. a Boxplot showing number of SCNA break...
Figure S1. Secreted factors from adipose stem cells promotes proliferation and migration of breast c...
Lapatinib treatment reduces collagen expression in the tumor stroma. A. H&E of tumors from control o...
Figure S8. The growth kinetics of MDA-468/shCtrl cells or MDA-468/shIRIS cell lines grown alone or i...
Figure S2. Anti-proliferative effect of RAD001 in combination with endocrine agents (a) 4-OHT and (b...
Figure S1: (A) Dysregulation score was calculated according to Pathifier [32] for MAPK and JAK/STAT ...
Cell growth kinetics in 2D cultures of human breast cancer cell lines after SPOCK1 silencing. A. Ana...
KaplanâMeier analysis in different molecular subtypes of breast cancer patients based on EPCR expr...
Clinical relevance of SPOCK1 in different breast cancer subtypes. A. Relapse-free survival analysis ...
Figure S2. ED and EAD induce cell growth arrest. (A) qRT-PCR of cyclin D1 (CCND1) and cyclin-depende...
Role of MAPK and PI3K pathways in APOBEC3 activation. a BT474 cells were treated with 10 nM afatinib...
PRKCQ downregulation in MDA-231-LucD3H2LN cells results in G2-M arrest. Triple-negative MDA-231-LucD...
Figure S7. Assessment of dynamic changes in expression of cell cycle regulatory genes. (a) Log2 diff...
Figure S7. Test of cell line-specific variance in colony-forming assay between 4T1.2-shLacZ and 4T1....
Role of MAPK and PI3K pathways in hydroxyurea-induced APOBEC3 activation. a MCF10A cells were treate...
APOBEC3B expression and activity in breast cancer cell lines. a Boxplot showing number of SCNA break...
Figure S1. Secreted factors from adipose stem cells promotes proliferation and migration of breast c...
Lapatinib treatment reduces collagen expression in the tumor stroma. A. H&E of tumors from control o...
Figure S8. The growth kinetics of MDA-468/shCtrl cells or MDA-468/shIRIS cell lines grown alone or i...
Figure S2. Anti-proliferative effect of RAD001 in combination with endocrine agents (a) 4-OHT and (b...
Figure S1: (A) Dysregulation score was calculated according to Pathifier [32] for MAPK and JAK/STAT ...